Free Trial
→ Trump’s New Dollar revealed (From Porter & Company) (Ad)tc pixel
LON:DXRX

Diaceutics Interim Earnings Report

Diaceutics logo
GBX 144.88 -8.12 (-5.31%)
As of 11:06 AM Eastern
ProfileEarnings HistoryForecast

Diaceutics EPS Results

Actual EPS
-GBX 2.84
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Diaceutics Announcement Details

Quarter
Interim
Date
9/23/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Diaceutics Earnings Headlines

Diaceutics (LON:DXRX) Stock Price Down 7.1% - Here's Why
May 26, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30801322
Diaceutics Issues Shares Under Employee Incentive Schemes in Latest Block Listing Update
April 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-shares-under-employee-incentive-schemes-in-latest-block-listing-update?utm_source=marketbeat.com&utm_medium=referral
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel
June 4 at 1:00 AM  |  Porter & Company (Ad)
Diaceutics Executes Routine Management Share Purchases Under Incentive Plan With No Change to Share Capital
April 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-executes-routine-management-share-purchases-under-incentive-plan-with-no-change-to-share-capital?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Issues New Shares to Trust as PDMRs Participate in Incentive Plan
February 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-new-shares-to-trust-as-pdmrs-participate-in-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
Diaceutics PLC Expands Employee Share Incentive Plan
November 28, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-plc-expands-employee-share-incentive-plan-2?utm_source=marketbeat.com&utm_medium=referral
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile
Earnings Tools